Mucinous Cystic Neoplasms in Male Patients: Histopathological and Molecular Diagnoses

Cystic mucinous neoplasms (MCNs) of the pancreas are rare cystic tumors, accounting for approximately 2-5% of all pancreatic neoplasms. They predominantly occur in premenopausal women and are typically located in the body or tail of the pancreas. Due to their potential for malignant transformation, especially in cases associated with invasive carcinoma such as pancreatic ductal adenocarcinoma, early detection, complete surgical resection, and rigorous postoperative surveillance are essential. The occurrence of MCNs in male patients is exceedingly rare, comprising only about 2% of reported cases, and often resulting in preoperative diagnostic challenges. Molecular analyses have identified a strong association between KRAS mutations and disease progression in MCNs, underscoring their potential role as prognostic markers despite limited diagnostic utility. In this report, we present two additional cases of MCNs in male patients, highlighting their histopathological features and the ancillary investigations undertaken to support diagnosis.

Authors

Institutions

Publication Details

Journal
Current Oncology
Published
2025-06-13
DOI
https://doi.org/10.3390/curroncol32060352
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mucinous Cystic Neoplasms in Male Patients: Histopathological and Molecular Diagnoses

Fabiola Rossi, Natale Calomino, Lucia Mundo, Adrienne V. Visani et al.
Current Oncology
Pancreatic and Hepatic Oncology Research
article

Mucinous Cystic Neoplasms in Male Patients: Histopathological and Molecular Diagnoses

Fabiola Rossi, Natale Calomino, Lucia Mundo, Adrienne V. Visani, Franco Roviello, Ilaria Monteleone, Lara Malaspina, Ludovico Carbone, Anastasia Batsikosta, Gianmario Edoardo Poto, Sergio Antonio Tripodi, Bina Barbato
article en

Abstract

Cystic mucinous neoplasms (MCNs) of the pancreas are rare cystic tumors, accounting for approximately 2-5% of all pancreatic neoplasms. They predominantly occur in premenopausal women and are typically located in the body or tail of the pancreas. Due to their potential for malignant transformation, especially in cases associated with invasive carcinoma such as pancreatic ductal adenocarcinoma, early detection, complete surgical resection, and rigorous postoperative surveillance are essential. The occurrence of MCNs in male patients is exceedingly rare, comprising only about 2% of reported cases, and often resulting in preoperative diagnostic challenges. Molecular analyses have identified a strong association between KRAS mutations and disease progression in MCNs, underscoring their potential role as prognostic markers despite limited diagnostic utility. In this report, we present two additional cases of MCNs in male patients, highlighting their histopathological features and the ancillary investigations undertaken to support diagnosis.

Current OncologyVol. 32(6)
University of Siena (IT), Accademia di Belle Arti di Carrara (IT), Ospedale Misericordia - Grosseto (IT)
Openalex Percentile: Top 79%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mucinous Cystic Neoplasms in Male Patients: Histopathological and Molecular Diagnoses — Fabiola Rossi, Natale Calomino, et al. · Current Oncology (2025) | TGRS Research Map | TGRS